What AI says about BPL Plasma

Kedrion Biopharma collects plasma and produces plasma-derived therapies for rare and ultra-rare diseases, including coagulation and neurological disorders, immunodeficiencies, and Rh sensitization. The company operates 68 plasma collection centers in the U.S., 8 in the Czech Republic, and 7 production facilities across 5 countries, distributing 38 products in over 100 countries.